deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05874284

The Effect of Prolotherapy in the Care Process of Pressure Injuries

The Effect of Prolotherapy in the Care of Pressure Injuries: A Randomized Controlled Study

Sponsor: Fenerbahce University

Conditions Pressure Ulcer
Interventions Gelofusin
Updated 5 times since 2023 Last updated: Feb 23, 2024 Started: Jun 10, 2023 Primary completion: Jun 15, 2023 Completion: Jun 20, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05874284, this EARLY_PHASE1 trial focuses on Pressure Ulcer and remains completed. Sponsored by Fenerbahce University, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jun 2023 – ~Mar 2024 · 9 months · monthly snapshotNot Yet Recruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed EARLY_PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed EARLY_PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  4. Mar 2024 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

    Status: Not Yet RecruitingCompleted

  5. Jun 2023 — Mar 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fenerbahce University
Data source: Fenerbahce University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations